Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00370669
Status:
UNKNOWN
Last Update Posted:
2007-02-22
First Post:
2006-08-30
Brief Title:
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Shahid Beheshti University of Medical Sciences
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2007-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone acetonide with laser photocoagulation on clinically significant macular edema CSME
Detailed Description:
we entered 150 eyes into the study that recruitment of cases finished recentlyEligible eyes randomly assign to one of the study arms including intravitreal bevacizumzb intravitreal bevacizumzbtriamcinolone and macular photocoagulation groups Every patient needs at least 1 year followup During this time BCVA OCT FA will be done for each patient and inaccording to interpretation of datas and fundus exam repeatation of injection will be done
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None